Endothelial Cell Complications after Allogeneic Stem Cell Transplantation, A Single Centre Analysis on 99 Consecutive Patients undergoing allo-sct

被引：0
|
作者：
Mancini, Giorgia [1 ]
Candelora, Matteo [2 ]
Urbano, Giuseppina [2 ]
Saraceni, Francesco [1 ]
Poiani, Monica [1 ]
Mariani, Marianna [1 ]
Federici, Irene [1 ]
Tarantino, Giuseppe [1 ]
Scortechini, Ilaria [1 ]
Olivieri, Attilio [1 ]
机构：
[1] Azienda Osped Univ Osped Riuniti Ancon, Ancona, Italy
[2] Univ Politecn Marche, Ancona, Italy
来源：
BONE MARROW TRANSPLANTATION | 2020年 / 55卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P551
引用
收藏
页码：599 / 599
页数：1
相关论文
共 50 条
  • [41] Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning (RIC) allogeneic stem cell transplantation (Allo-SCT)
    Mohty, M
    Avinens, O
    Faucher, C
    Furst, S
    Viens, P
    Gastaut, JA
    Eliaou, JF
    Blaise, D
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 33 - 33
  • [42] Dose conversion from intravenous cyclosporine (CsA) to the new oral formulation (Neoral) in patients undergoing stem cell transplantation (allo-SCT).
    Vallejo, C
    Cano, H
    Ruiz, F
    Gonzalez, A
    Heras, I
    Arriba, F
    Moraleda, JM
    Vicente, V
    BLOOD, 2000, 96 (11) : 335B - 335B
  • [43] Feasibility of early administration of 5-azacytidine (5-AZA) for prevention of relapse after allogeneic stem cell transplantation (allo-SCT)
    Le Bourgeois, A.
    Martin, J. -E.
    Dulery, R.
    Battipaglia, G.
    Belhocine, R.
    Eder, S.
    Giannotti, F.
    Isnard, F.
    Lapusan, S.
    Legrand, O.
    Rubio, M. -T.
    Verkhoff, A.
    Ruggeri, A.
    Brissot, E.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S243 - S243
  • [44] Long-Term Immune Deficiency (ID) after Allogeneic Stem Cell Transplantation (allo-SCT) Following a Myeloablative (MA) Conditioning Regimen
    Corre, Elise
    Cannagnat, Maryvonnick
    Busson, Marc
    de Latour, Regis Peffault
    Robin, Marie
    Ribaud, Patricia
    Toubert, Antoine
    Rabian, Claire
    Socie, Gerard
    BLOOD, 2008, 112 (11) : 742 - 743
  • [45] A Scoring System Predictive of Extensive Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Stem Cell Transplantation (allo-SCT)
    Brissot, Eolia
    Foucher, Yohann
    Malard, Florent
    Peric, Zinaida
    Clavert, Aline
    Chevallier, Patrice
    Guillaume, Thierry
    Delaunay, Jacques
    Ayari, Sameh
    Harousseau, Jean-Luc
    Moreau, Philippe
    Coste-Burel, Marianne
    Imbert-Marcille, Berthe-Marie
    Gregoire, Marc
    Braudeau, Cecile
    Josien, Regis
    Gaugler, Beatrice
    Mohty, Mohamad
    BLOOD, 2011, 118 (21) : 864 - 864
  • [46] Platelets recovery and transfusion needs after reduced intensity conditioning (RIC) allogeneic peripheral blood stem cell (PBSC) transplantation (allo-SCT).
    Prebet, Thomas
    Mohty, Mohamad
    Ladaique, Patrick
    Chabannon, Christian
    Faucher, Catherine
    Furst, Sabine
    de, Hugues Lavallade
    El-Cheikh, Jean
    Viens, Patrice
    Gastaut, Jean-Albert
    Blaise, Didier
    BLOOD, 2006, 108 (11) : 847A - 847A
  • [47] AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) VS ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) AS FIRST TRANSPLANT PROCEDURE IN PATIENTS WITH WALDESTROM MACROGLOBULINEMIA. RESULTS OF A RETROSPECTIVE ANALYSIS OF THE LYMPHOMA WORKING PARTY OF THE EBMT
    Sureda, A.
    Canals, C.
    Kyriakou, C.
    Gisselbrecht, C.
    Gramatzki, M.
    Kazmi, M.
    Cahn, J. Y.
    Milpied, N.
    Kolbe, K.
    Arcese, W.
    Corradini, P.
    Niederwieser, D.
    Jouet, J. P.
    Thomson, K.
    Hamladji, R. M.
    Indrak, K.
    Schmitz, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 201 - 202
  • [48] Severe central nervous system complications after allogeneic stem cell transplantation (SCT)
    Schäfer-Eckart, K
    Fürst, S
    Reinel, H
    Birkmann, J
    Gallmeier, W
    Wandt, H
    BONE MARROW TRANSPLANTATION, 2002, 29 : S218 - S218
  • [49] Risk Factors and Clinical Impact of Chronic Kidney Disease (CKD) after Allogeneic Stem Cell Transplant (allo-SCT)
    Shimizu, Hiroaki
    Ishizaki, Takuma
    Hatsumi, Nahoko
    Takada, Satoru
    Yokohama, Akihiko
    Saitoh, Takayuki
    Nojima, Yoshihisa
    Handa, Hiroshi
    BLOOD, 2016, 128 (22)
  • [50] Optimal Timing of Allogeneic Stem Cell Transplantation (Allo-SCT) for Chronic Myeloid Leukemia (CML) Patients in the Tyrosine Kinase Inhibitor (TKI) Era
    Hu, Bei
    Lin, Xiao
    Lee, Hans C.
    Huang, Xuelin
    Slack, Rebecca
    Jabbour, Elias J.
    Verstovsek, Srdan
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Champlin, Richard E.
    Hu, Zhen-Huan
    Ahn, Kwang Woo
    Lee, Ying
    Popat, Uday
    Sobecks, Ronald
    Alyea, Edwin
    Kantarjian, Hagop M.
    Cortes, Jorge E.
    Saber, Wael
    BLOOD, 2017, 130
12345